Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.8.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating expenses:    
Research and development $ 28,460 $ 17,541
General and administrative 13,992 8,620
Total operating expenses 42,452 26,161
Loss from operations (42,452) (26,161)
Interest and other income, net 1,009 509
Loss before provision for income taxes (41,443) (25,652)
Provision for income taxes 0 2
Net loss (41,443) (25,654)
Other comprehensive loss:    
Unrealized gain (loss) on available-for-sale securities (373) 31
Comprehensive loss $ (41,816) $ (25,623)
Net loss per common share:    
Basic and diluted net loss per common share $ (1.05) $ (0.88)
Weighted-average shares outstanding used to calculate basic and diluted net loss per common share 39,596 29,056